J. Mark Jackson, MD
Board-Certified Dermatologist
The overall well-being of each patient in my care is important to me. I approach their treatment as I would that of my own family.
- J. Mark Jackson, MD


Undergraduate Degree:
Baylor University, TX
Medical Degree:
Texas A&M College of Medicine, TX
Internal Medicine Internship:
Texas A&M University College of Medicine
Dermatology Residency:
University of Louisville, KY


Board-Certified Dermatologist (American Board of Dermatology)

Professional Memberships

Dermatology Foundation Leaders Society
Medical Dermatology Society
American Academy of Dermatology
American Board of Dermatology
American Acne and Rosacea Society
American Medical Association
Kentucky Dermatological Association
Kentucky Medical Association
Greater Louisville Medical Society
North American Rheumatologic Dermatology Society
Jefferson County Medical Society


Voted Best Dermatologist Louisville Magazine
Upjohn Achievement Award for Virtues Most Admired in a Physician
Department of Internal Medicine Award for Excellence
Class President
Golden Apple Award for Outstanding Resident Teacher
Roche Overall Award for Clinical Research, Resident/Intern Division
American Academy of Family Physicians Award for Research
Chief Resident
Team dermatologist for University of Louisville Athletics
Chairman/spokesperson Christ Church United Methodist capital campaign
Chairman of Finance Committee Christ Church United Methodist
Active involvement on church administrative council, finance committee, long-range planning committee & preschool board
Capital campaign steering sommittee for Kentucky Country Day School
Little League baseball coach and middle school basketball coach


Jackson JM, Fowler JF, Callen JP, Lorenz DJ; Mycophenolate mofetil for the treatment An open-label study. J Drugs Dermatol 2010;9:356-62.

Fowler J, Jackson, J, Jarrat M, et al: Once Daily brimonidine tartrate gel 0.5% is a moderate to severe facial erythema of rosacea: results of two randomized, multi-centre, vehicle controlled studies. Br J Dermatol 2012:166:633-41.

Fowler JF, Jackson JM, Steinhoff M, et al: Topical brimonidine tartrate gel is safe and treatment of moderate to severe facial erythema of rosacea. JDrugsDermatol, June 2013.